IRIX vs TECH · rev $12.6M vs P/E 65, rev $1.22B
IRIDEX Corporation (IRIX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
IRIDEX Corporation (IRIX) is a medical devices company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported IRIX revenue for 2026-07-04 was $12.6M. Net income was -$1.3M. Revenue was up 6.5% from 2026-04-04 to 2026-07-04. IRIX currently screens at market cap $19.0M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
IRIX currently screens at market cap $19.0M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the IRIX and TECH stock pages for the full models.
Not investment advice.